RxDoctor Payments Data

Pradeep Mathur, MD

Psychiatry · Boardman, OHNPI 1053373159

Payments from drug & device makers

$9,646in general payments, 2019–2025

Across 554 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Corium, LLC$918
  • Axsome Therapeutics, Inc.$775
  • Vanda Pharmaceuticals Inc.$718
  • Ironshore Pharmaceuticals Inc.$686
  • E.r. Squibb & Sons, L.L.C.$561
  • plus $5K from 28 others

What the payments were for

  • Food & beverage$9,53699%
  • Education$1071%
  • Gifts$30%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,646 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio

Medicare billing

Part B allowed, 2024
$17,012
Medicare patients
64
Services billed
192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LybalviOlanzapine/Samidorphan Malate17$45,699
AuvelityDextromethorphan Hbr/Bupropion32$43,849
VraylarCariprazine Hcl13$31,878
TrintellixVortioxetine Hydrobromide25$24,099
VyvanseLisdexamfetamine Dimesylate40$18,793
Methylphenidate ErMethylphenidate Hcl36$10,973
Aripiprazole39$9,347
Doxepin Hcl47$6,665
Ziprasidone Hcl32$6,106
Atomoxetine Hcl24$4,627
Bupropion XlBupropion Hcl153$4,161
MydayisDextroamphetamine/Amphetamine12$3,961
Methylphenidate Er (La)Methylphenidate Hcl18$3,151
Duloxetine Hcl99$3,084
Venlafaxine Hcl ErVenlafaxine Hcl31$2,129

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Lybalvi$221$45,69917 claims
Axsome Therapeutics, Inc.Auvelity$775$43,84932 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$485$42,89265 claims
AbbVieVraylar$1,357$31,87813 claims
Shire North American Group IncMydayis$115$3,96112 claims
Almatica Pharma LLCSertraline Hcl$101$65739 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,119 psychiatry providers in Ohio.

Other psychiatry in Boardman

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →